Results 11 to 20 of about 2,229,300 (191)
Severe community-acquired pneumonia
European Respiratory Review, 2022 Severe community-acquired pneumonia is the most life-threatening form of community-acquired pneumonia, characterised by intensive care unit admission and high morbidity and mortality.
Michael S. Niederman, Antoni Torres
doaj +3 more sources
Interleukin-40 as a biomarker of mortality risk in patients with severe pneumonia [PDF]
Frontiers in ImmunologySevere pneumonia is an acute lung parenchyma infectious disease with a high incidence and mortality. The role of interleukin-40 (IL-40) in estimating mortality in patients with severe pneumonia remains unknown.
Hong Tan +4 more
doaj +2 more sources
Thrombosis biomarkers: utility in early diagnosis and prognosis of severe pneumonia [PDF]
Thrombosis JournalBackground Pneumonia is a major health problem and the most important causes of mortality in all age groups worldwide. We investigated new automation technology to detect plasma biomarkers, including thrombinantithrombin complex (TAT), α2 ...
Yanru Fan +5 more
doaj +2 more sources
MiR-331-3p serves as a diagnostic biomarker in children with severe pneumonia [PDF]
BMC ImmunologyBackground Severe pneumonia poses a life-threatening risk to children’s physical health. This study aimed to evaluate the diagnostic value of serum miR-331-3p in pediatric severe pneumonia.
Xiaoya Si +5 more
doaj +2 more sources
A case report on management of severe childhood pneumonia in low resource settings [PDF]
Respiratory Medicine Case Reports, 2018 Pneumonia is a major cause of child mortality among children under five years, worldwide. Pneumonia infection may be caused by bacteria, viruses, or fungi in single or in both lungs.
Yasmin Jahan, Atiqur Rahman
doaj +2 more sources
Severe community-acquired pneumonia [PDF]
Current Opinion in Pulmonary Medicine, 1996 Community-acquired pneumonia is an important public health concern and a recent focus of clinical practice guidelines. What has become clear from this renewed focus of attention is that a subgroup of patients with community-acquired pneumonia have severe disease with a differing spectrum of pathogens and prognosis.
H A, Cassiere, A M, Fein
core +4 more sources
Jurnal Respirasi, 2019 Background: Severe pneumonia is still a serious problem with high mortality rate. The cause of severe pneumonia due to high inflammation or different microbial pattern compared to non-severe pneumonia is still unknown.
Daniel Maranatha, Mawardi Mawardi
doaj +2 more sources
Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments
International Journal of Infectious Diseases, 2020 Objective: The risk factors and the impact of NAI treatments in patients with severe influenza A-associated pneumonia remain unclear. Methods: A multicenter, retrospective, observational study was conducted in Zhejiang, China during a severe influenza ...
Qianda Zou +20 more
doaj +3 more sources
Statins Reduce Mortality After Non-severe but Not After Severe Pneumonia: A Systematic Review and Meta-Analysis [PDF]
Journal of Pharmacy & Pharmaceutical Sciences, 2015 PURPOSE: The objective of this study was to perform a systematic review and meta-analysis of the effects of statins on mortality for patients with non-severe pneumonia or severe pneumonia. METHODS: PubMed, EMBASE, Cochrane Database of Systematic Reviews,
Mingwang Jia +4 more
doaj +2 more sources
Continuous Professional Oral Health Care Intervention Improves Severe Aspiration Pneumonia
Case Reports in Dentistry, 2019 Professional oral health care (POHC) is known to prevent aspiration pneumonia in patients with dysphagia and/or those at the perioperative stage of surgery. However, the effect of POHC on patients suffering from aspiration pneumonia remains unknown. Here,
Wakako Nawata +9 more
doaj +2 more sources